✦ LIBER ✦

Absence of increased succinylacetone in the urine of a child with hereditary tyrosinaemia type I

✍ Scribed by A. A. M. Haagen; M. Duran

Publisher: Springer
Year: 1987
Tongue: English
Weight: 203 KB
Volume: 10
Category: Article
ISSN: 0141-8955
DOI: 10.1007/bf01811440

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dietary treatment eliminates succinylace

Dietary treatment eliminates succinylacetone from the urine of a patient with tyrosinaemia type 1

✍ M. D. Bain; P. Purkiss; M. Jones; P. Bingham; T. E. Stacey; R. A. Chalmers 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 305 KB

A CASE OF TYROSINAEMIA TYPE I WITH NORMA

A CASE OF TYROSINAEMIA TYPE I WITH NORMAL LEVEL OF SUCCINYLACETONE IN THE AMNIOTIC FLUID

✍ A. GRENIER; S. CEDERBAUM; C. LABERGE; R. GAGNÉ; C. JAKOBS; R. M. TANGUAY 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 333 KB 👁 1 views

Prenatal diagnosis of tyrosinaemia type I can be achieved in cultured amniotic cells and in chorionic villus material by testing the activity of fumarylacetoacetate hydrolase and by DNA analysis, and in amniotic fluid by succinylacetone measurement. This specific metabolite can be measured either by

Genotyping of a case of tyrosinaemia typ

Genotyping of a case of tyrosinaemia type I with normal level of succinylacetone in amniotic fluid

✍ Jacques Poudrier; Francine Lettre; Maryse St-Louis; Robert M. Tanguay 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 1 views

Tyrosinaemia type I is caused by a deficiency of fumarylacetoacetate hydrolase and mainly affects the liver. This disease is characterized by the presence of a high level of succinylacetone. This metabolite has been used for prenatal diagnosis from amniotic fluid samples. One case with a normal leve

Hereditary tyrosinaemia type I: A long-t

Hereditary tyrosinaemia type I: A long-term study of the relationship between the urinary excretions of succinylacetone and δ-aminolevulinic acid

✍ H. Schierbeek; G. J. J. Beukeveld; H. Faassen; F. J. Spronsen; K. Bijsterveld; E 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 418 KB

Successful treatment of severe cardiomyo

Successful treatment of severe cardiomyopathy with NTBC in a child with tyrosinaemia type I

✍ N. André; B. Roquelaure; V. Jubin; C. Ovaert 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 110 KB

Severe neurological crisis in a patient

Severe neurological crisis in a patient with hereditary tyrosinaemia type I after interruption of NTBC treatment

✍ J.-U. Schlump; C. Perot; K. Ketteler; M. Schiff; E. Mayatepek; U. Wendel; U. Spi 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 72 KB